menu search

Alnylam pharmaceuticals, inc. (alny) q2 2023 earnings call transcript

Alnylam pharmaceuticals, Inc. (NASDAQ:ALNY ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM ET...

August 3, 2023, 1:40 pm

Regeneron pharmaceuticals inc: a biotech powerhouse with high outperformance potential

Regeneron pharmaceuticals Inc ( REGN , Financial), a leading player in the biotechnology industry, is c...

August 3, 2023, 12:58 pm

Biocryst pharmaceuticals, inc. (bcrx) q2 2023 earnings call transcript

BioCryst pharmaceuticals, Inc. (NASDAQ:BCRX ) Q2 2023 Earnings Conference Call August 3, 2023 8:30 AM E...

August 3, 2023, 12:55 pm

Teva agrees to pay $126 mln to us hospitals over opioids

Teva pharmaceutical Industries Ltd has agreed to pay up to $126 million to U.S. hospitals over 18 years...

August 3, 2023, 12:47 pm

Agios pharmaceuticals, inc. (agio) q2 2023 earnings call transcript

Agios pharmaceuticals, Inc. (NASDAQ:AGIO ) Q2 2023 Results Conference Call August 3, 2023 8:00 AM ET Co...

August 3, 2023, 11:55 am

Drug sales surge drives regeneron pharmaceuticals to q2 beat

Regeneron pharmaceuticals Inc  (NASDAQ:REGN) reported second-quarter revenue of $10.24 per share on ...

August 3, 2023, 10:40 am

Shareholder investigation: halper sadeh llc investigates reta, eqrx, dffn

NEW YORK, Aug. 03, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vio...

August 3, 2023, 10:23 am

Aurinia pharmaceuticals (auph) reports q2 loss, tops revenue estimates

Aurinia pharmaceuticals (AUPH) came out with a quarterly loss of $0.08 per share versus the Zacks Conse...

August 3, 2023, 9:00 am

Moleculin to report second quarter financial results on august 11, 2023 and host conference call and webcast

HOUSTON , Aug. 3, 2023 /PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage ...

August 3, 2023, 8:45 am

Regeneron's stock rallies after profit, revenue rise above expectations, amid a jump in collaboration revenue

Shares of Regeneron pharmaceuticals Inc. REGN, -0.94% climbed 2.6% toward a 5-week high in premarket tr...

August 3, 2023, 8:11 am

Nkarta to participate at upcoming investor conference

SOUTH SAN FRANCISCO, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutica...

August 3, 2023, 8:02 am

Altimmune to report second quarter 2023 financial results and provide business update on august 10, 2023

GAITHERSBURG, Md., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharma...

August 3, 2023, 7:30 am

Plus therapeutics to present at the canaccord genuity 43rd annual growth conference

AUSTIN, Texas, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage ...

August 3, 2023, 7:00 am

Regeneron pharma beats profit estimates on dupixent demand

Regeneron pharmaceuticals Inc beat Wall Street estimates for quarterly profit on Thursday, driven by st...

August 3, 2023, 6:37 am

Here's why investors should buy these 2 medical stocks after earnings

Following their favorable Q2 reports now looks like a good time to buy Encompass Health (EHC) and Vertex pharm...

August 3, 2023, 2:59 am

Rocket pharmaceuticals: thriving gene therapy with multiple catalysts

Rocket pharmaceuticals is developing gene therapies for rare diseases, with positive results and safety...

August 3, 2023, 12:42 am

Quoin pharmaceuticals provides corporate update and announces second quarter 2023 financial results

Company reports positive clinical data for first subject to complete testing in ongoing open-label Netherton Syndrome study Subject’s skin was asses...

August 2, 2023, 8:45 pm

Ventyx biosciences to participate in the canaccord genuity 43rd annual growth conference

SAN DIEGO, Aug. 02, 2023 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage bio...

August 2, 2023, 8:06 pm

Acadia pharmaceuticals (acad) q2 earnings and revenues beat estimates

Acadia pharmaceuticals (ACAD) came out with quarterly earnings of $0.01 per share, beating the Zacks Co...

August 2, 2023, 6:43 pm

Vertex pharmaceuticals (vrtx): a fairly valued stock with strong growth prospects

Vertex pharmaceuticals Inc ( VRTX , Financial) saw a daily gain of 3.07%, with an Earnings Per Share (E...

August 2, 2023, 6:33 pm


Search within

Pages Search Results: